- Duke Researchers Find Role for miR-126/miR-126* in Stopping Breast Cancer Metastasis
March 7, 2013 / Gene Silencing News
- Hearing on Second-Opinion Genetic Testing Highlights Risks of Athena's Exclusive Licensing Practices
January 16, 2013 / Pharmacogenomics Reporter
- Duke Licenses NPM1 from Trovagene for AML Research, Testing
December 27, 2012 / GenomeWeb Daily News
- IP Watch: PrimeraDx, Hologic, Life Tech, Agilent, Luminex, 3M, Canon, Others Win US Patents
November 29, 2012 / PCR Insider
- CardioDx Joins Duke, NHLBI Coronary Artery Disease Research Effort
November 27, 2012 / GenomeWeb Daily News